These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26484391)

  • 21. PhID: An Open-Access Integrated Pharmacology Interactions Database for Drugs, Targets, Diseases, Genes, Side-Effects, and Pathways.
    Deng Z; Tu W; Deng Z; Hu QN
    J Chem Inf Model; 2017 Oct; 57(10):2395-2400. PubMed ID: 28906116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case.
    Ortiz de García S; Pinto GP; García-Encina PA; Irusta Mata RI
    J Environ Manage; 2013 Nov; 129():384-97. PubMed ID: 23995140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacotherapy of hyperthyreosis--adverse drug reactions].
    Perger L; Bürgi U; Fattinger K
    Ther Umsch; 2011 Jun; 68(6):303-8. PubMed ID: 21656488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GESSE: Predicting Drug Side Effects from Drug-Target Relationships.
    Pérez-Nueno VI; Souchet M; Karaboga AS; Ritchie DW
    J Chem Inf Model; 2015 Sep; 55(9):1804-23. PubMed ID: 26251970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordination chemistry of Group 12 metals with phosphorodiselenoates: syntheses, structures and VT 31P NMR study of monomer-dimer exchange equilibrium.
    Liu CW; Lobana TS; Santra BK; Hung CM; Liu HY; Liaw BJ; Wang JC
    Dalton Trans; 2006 Jan; (4):560-70. PubMed ID: 16402142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel semisupervised algorithm for rare prescription side effect discovery.
    Reps JM; Garibaldi JM; Aickelin U; Soria D; Gibson JE; Hubbard RB
    IEEE J Biomed Health Inform; 2014 Mar; 18(2):537-47. PubMed ID: 24043412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Neural Network Approach to Predict Drug-Target Interactions Based on Drug Side Effects and Genome-Wide Association Studies.
    Prinz J; Koohi-Moghadam M; Sun H; Kocher JA; Wang J
    Hum Hered; 2018; 83(2):79-91. PubMed ID: 30347404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drugs and indications in 2013: little real progress but regulatory authorities take some positive steps.
    Prescrire Int; 2014 Apr; 23(148):107-10. PubMed ID: 24860905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of clinical risks by analysis of preclinical and clinical adverse events.
    Clark M
    J Biomed Inform; 2015 Apr; 54():167-73. PubMed ID: 25746390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials].
    Dejas-Eckertz P; Schäffner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):423-8. PubMed ID: 15830253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monitoring dermatomal somatosensory evoked potentials at the ERB point, the cervical spinal cord and the cerebral cortex in the diagnosis of cervical radiculopathy].
    Talavera-Carbajal MR; Estañol-Vidal B; López-Lomelí MM; García-Ramos G; Corona V; Plascencia N; Domínguez JC; Facha-García MT; Valdivieso-Cárdenas GE; Carrillo P; Olivas E; Veláquez M
    Rev Neurol; 2003 May 16-31; 36(10):917-24. PubMed ID: 12766863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Ensemble Approach for Drug Side Effect Prediction.
    Jahid MJ; Ruan J
    Proceedings (IEEE Int Conf Bioinformatics Biomed); 2013; ():440-445. PubMed ID: 25327524
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of new technologies to characterization and prediction of adverse effects.
    Rouquié D; Heneweer M; Botham J; Ketelslegers H; Markell L; Pfister T; Steiling W; Strauss V; Hennes C
    Crit Rev Toxicol; 2015 Feb; 45(2):172-83. PubMed ID: 25615431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic drug safety evaluation based on public genomic expression (Connectivity Map) data: myocardial and infectious adverse reactions as application cases.
    Wang K; Weng Z; Sun L; Sun J; Zhou SF; He L
    Biochem Biophys Res Commun; 2015 Feb; 457(3):249-55. PubMed ID: 25576362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adverse drug reactions and interactions - cause of admission to hospital and after discharge].
    Hippius M
    Ther Umsch; 2011 Jan; 68(1):47-53. PubMed ID: 21184394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the causative proteins of similar side effect pairs to explore the common molecular basis of these side effects.
    Wang Y; Chen X; Liu L; Chen Y; Ma H; Yang R; Liu X
    Mol Biosyst; 2015 Jul; 11(7):2060-7. PubMed ID: 25992869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.